Sell Thesis Reinforces Execution and Funding Risks as Nebius Faces Key Proof Points
Read source articleWhat happened
A new Seeking Alpha article reiterates a Sell call on Nebius, arguing that Q3 revenue excluding $325M of non-recurring items was only $656M, undermining confidence in the $6.4B annualized revenue run-rate and highlighting that the $40-45B 2027 capex plan will constrain cash generation and equity claims. This challenges the DeepValue master report's 'POTENTIAL BUY' rating, which acknowledged non-recurring revenue but leaned on strong demand, $38.7B RPO, and near-term proofs like ARR above $7B by February 2027 and non-dilutive funding. The market has already priced in much of this anxiety: NBIS fell from about $277 in August to roughly $97 by late November, a 65% drawdown. Management's credibility now hinges on hitting the February ARR target and securing asset-backed financing at reasonable terms, with any miss likely to trigger another leg down. The debate has shifted from demand quantity to revenue quality and funding mix, with the bear case gaining traction until those proofs are delivered.
Implication
The short-term risk/reward is unfavorable because contracted demand has not translated into clean recurring revenue, and the enormous 2027 capex plan requires funding that may dilute equity. The DeepValue base case (45% probability, $120 value) now looks optimistic because it assumes ARR > $7B by Feb 2027 and >75% non-dilutive capex coverage, both unproven and contradicted by recent data. The bear case (30%, $65 value) becomes more likely if Microsoft-related capacity slips further or if the company raises equity again. Investors should wait for the February 2027 ARR update and evidence of asset-backed financing before initiating or adding; a break above $135 would invalidate the bear thesis, while a drop below $85 would be attractive only if funding is secured.
Thesis delta
The new Sell thesis directly attacks the core assumptions of the POTENTIAL BUY call: it claims the revenue base is inflated by one-offs and that the $6.4B ARR is unreliable, while capex outruns cash generation. This adds weight to the bear case but does not fully invalidate the bull case because the key binary events (ARR proof, financing mix) are still pending. Confidence in the POTENTIAL BUY rating should be reduced from 3.5 to around 2.5 until these proofs are delivered.
Confidence
Medium